DJM has served in the past year and will serve in the coming year on the speakers bureau for AstraZeneca, Bristol-Myers Squibb, Pfizer, Sepracor, and Wyeth; and is a member of the scientific advisory board for AstraZeneca.
Pharmacologic treatment of rapid cycling and mixed states in bipolar disorder: an argument for the use of lithium
Version of Record online: 1 JUN 2009
© 2009 John Wiley & Sons A/S
Special Issue: Lithium and the Modern Management of Bipolar Disorder
Volume 11, Issue Supplement s2, pages 84–91, June 2009
How to Cite
Muzina, D. J. (2009), Pharmacologic treatment of rapid cycling and mixed states in bipolar disorder: an argument for the use of lithium. Bipolar Disorders, 11: 84–91. doi: 10.1111/j.1399-5618.2009.00713.x
- Issue online: 1 JUN 2009
- Version of Record online: 1 JUN 2009
- Received 9 December 2008, revised and accepted for publication 3 April 2009
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.